Find clinical trials for AstraZeneca. Search for AstraZeneca clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 139
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fairhaven MA, Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
for
Moderate Hepatic Impairment
Location: San Antonio TX, Rialto CA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07343960
Phase 1, Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
for
Systemic Lupus Erythematosus,
Location: Sherbrooke, Hamilton, Anniston AL, Iowa City IA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06916806
Phase 1, Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for
Non-small Cell Lung Cancer,
Location: Boston MA, New York NY, New Brunswick NJ, Pittsburgh PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05877599
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Boston MA, Miami FL, Tampa FL, Chicago IL, Omaha NE
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06879041
Phase 1, Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
for
Diffuse Large B-Cell Lymphoma
Location: Towson MD, Beltsville MD, Jacksonville FL, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 65 - 70+
Code: NCT05952024
Phase 2, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase 1, Phase 2, Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: New York NY, Richmond VA, Toronto, Tampa FL, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137118
Phase 1, Phase 2, Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: Boston MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06564038
Phase 1, Phase 2, Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Boston MA, New Haven CT, Montreal, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05061550
Phase 2, Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Location: Boston MA, Providence RI, Montreal, Fairfax VA, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05797168
Phase 1, Phase 2, Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
for
Asthma
Location: Worcester MA, Maspeth NY, Toms River NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06932263
Phase 2, Recruiting
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
for
Systemic Lupus Erythematosus
Location: Wilmington NC
Sponsor: AstraZeneca
Sex: Female
Age: 0+
Code: NCT06659029
Recruiting
Study of AZD0754 in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: New York NY, Hackensack NJ, Philadelphia PA, Tampa FL,